Jiangzhong Pharmaceutical Co Ltd Strategic Asset Allocation Index

Latest as of June 2023: 34.8%

Jiangzhong Pharmaceutical Co Ltd strategic asset allocation index. Jiangzhong Pharmaceutical Co Ltd (600750) has a Strategic Asset Allocation Index of 34.8% as of June 2023. Strategic assets (PP&E of CN¥1.59 Billion plus long-term investments of CN¥-) total CN¥1.59 Billion, measured against net assets of CN¥4.57 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 600750 equity to assets ratio to measure how much of total assets are equity-financed.

SAAI

34.8%
Strategic Assets / Net Assets

Strategic Assets

CN¥1.59 Billion
PP&E + LT Investments

PP&E

CN¥1.59 Billion
CNY

Net Assets

CN¥4.57 Billion
CNY

Strategic Asset Allocation Index of Jiangzhong Pharmaceutical Co Ltd (2000–2022)

Strategic asset allocation index of Jiangzhong Pharmaceutical Co Ltd from 2000 to 2022. This chart shows how Jiangzhong Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 34.8%, representing strategic assets of CN¥1.59 Billion against net assets of CN¥4.57 Billion CNY. Check 600750 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Jiangzhong Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2000–2022)

Jiangzhong Pharmaceutical Co Ltd strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Jiangzhong Pharmaceutical Co Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Jiangzhong Pharmaceutical Co Ltd.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2022 33.7% CN¥1.52 Billion CN¥1.52 Billion CN¥- CN¥4.51 Billion ▲ +7.1 pp
2021 26.6% CN¥1.22 Billion CN¥1.22 Billion CN¥- CN¥4.58 Billion ▲ +2.6 pp
2020 24.0% CN¥1.02 Billion CN¥1.02 Billion CN¥- CN¥4.25 Billion ▼ -8.6 pp
2019 32.6% CN¥1.28 Billion CN¥1.06 Billion CN¥218.27 Million CN¥3.92 Billion ▼ -2.6 pp
2018 35.3% CN¥1.15 Billion CN¥954.48 Million CN¥192.92 Million CN¥3.25 Billion ▼ -0.1 pp
2017 35.3% CN¥1.03 Billion CN¥843.85 Million CN¥186.59 Million CN¥2.92 Billion ▼ 0.0 pp
2016 35.4% CN¥925.65 Million CN¥722.22 Million CN¥203.43 Million CN¥2.62 Billion ▼ -3.3 pp
2015 38.7% CN¥910.50 Million CN¥718.63 Million CN¥191.87 Million CN¥2.35 Billion ▲ +3.6 pp
2014 35.1% CN¥749.14 Million CN¥749.14 Million CN¥- CN¥2.13 Billion ▼ -19.3 pp
2013 54.5% CN¥1.16 Billion CN¥1.16 Billion CN¥- CN¥2.13 Billion ▼ -4.5 pp
2012 58.9% CN¥1.21 Billion CN¥1.21 Billion CN¥- CN¥2.05 Billion ▲ +4.7 pp
2011 54.2% CN¥1.04 Billion CN¥1.04 Billion CN¥- CN¥1.92 Billion ▲ +6.4 pp
2010 47.9% CN¥851.62 Million CN¥851.62 Million CN¥- CN¥1.78 Billion ▼ -24.4 pp
2009 72.3% CN¥775.62 Million CN¥775.62 Million CN¥- CN¥1.07 Billion ▼ -12.4 pp
2008 84.7% CN¥821.35 Million CN¥821.35 Million CN¥- CN¥969.41 Million ▲ +14.0 pp
2007 70.8% CN¥592.98 Million CN¥592.98 Million CN¥- CN¥837.97 Million ▼ -16.1 pp
2006 86.9% CN¥650.33 Million CN¥650.33 Million CN¥- CN¥748.62 Million ▼ -8.7 pp
2005 95.6% CN¥671.08 Million CN¥671.08 Million CN¥- CN¥702.13 Million ▲ +0.5 pp
2004 95.1% CN¥630.13 Million CN¥630.13 Million CN¥- CN¥662.81 Million ▲ +19.1 pp
2003 76.0% CN¥486.26 Million CN¥486.26 Million CN¥- CN¥639.80 Million ▲ +33.4 pp
2002 42.6% CN¥245.03 Million CN¥245.03 Million CN¥- CN¥575.21 Million ▲ +12.6 pp
2001 30.0% CN¥165.10 Million CN¥165.10 Million CN¥- CN¥551.04 Million ▼ -7.1 pp
2000 37.0% CN¥202.19 Million CN¥202.19 Million CN¥- CN¥545.76 Million —
pp = percentage points